The protein profile of acetazolamide-treated sera in mice bearing Lewis neoplasm

Life Sciences

Volumn 75, Issue 11, 2004, Pages 1277-1285

  Xiang, Yang ^a,c   Ma, Bing ^a   Yu, He Ming ^b   Li, Xue Jun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

Acetazolamide; Neoplasm; Proteomics

Indexed keywords

ACETAZOLAMIDE; HISTONE H2B; PROTEOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; LEWIS CARCINOMA; MASS SPECTROMETRY; METASTASIS; METASTASIS INHIBITION; MOUSE; MOUSE STRAIN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACETAZOLAMIDE; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; CARBONIC ANHYDRASE INHIBITORS; CARCINOMA, LEWIS LUNG; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; PROTEOME;

EID: 3042638412     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.12.032     Document Type: Article

References (13)

1. Hanash S.M., Madoz-Gurpide J., Misek D.E. Identification of novel targets for cancer therapy using expression proteomics. Leukemia. 16(4):2002;478-485
2. Hoving S., Voshol H., van Oostrum J. Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electropheresis. 21(13):2000;2617-2621
3. Ma L., Broomfield S., Lavery C., Lin S.L., Xiao W., Bacchetti S. Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines. Oncogene. 17(10):1998;1321-1326
4. Martini E.M., Keeney S., Osley M.A. A Role for Histone H2B During Repair of UV-Induced DNA Damage in Saccharomyces cerevisiae. Genetics. 160(4):2002;1375-1387
5. Ostergaard M., Rasmussen H.H., Nielsen H.V., Vorum H., Orntoft T.F., Wolf H., Celis J.E. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Research. 57(18):1997;4111-4117
6. Poon T.C.W., Johnson P.J. Proteome analysis and its impact on the discovery of serological tumor markers. Clinical Chimistry Acta. 313(1-2):2001;231-239
7. Rothofsky M.L., Lin S.L. CROC-1 encodes a protein which mediates transcriptional activation of the human FOS promoter. Gene. 195(2):1997;141-149
8. Sancho E., Vila M.R., Sanchez-Pulido L., Lozano J.J., Paciucci R., Nadal M. Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells. Molecular Cell Biology. 18(1):1998;576-589
9. Supuran C.T., Scozzafava A. Carbonic anhydrase inhibitors - Part 94. 1, 3, 4-Thiadiazole-2-sulfonamide derivatives as antitumor agents? European Journal Medical Chemistry. 35(9):2000;867-874
10. Wang J.L., Wan J.H., Luo L., Xiong S.X., Wang G.H., He F.C. Development and preliminary application of a peptide mass fingerprinting technique in proteome research. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Acta Bioch Bioph Sin). 32(4):2000;373-378
11. Xiang Y., Ma B., Li T., Yu H.M., Li X.J. Acetazolamide suppresses tumor metastasis and protein alteration of lung in mice bearing Lewis lung carcinoma. Acta Pharmacologica Sinica. 23(8):2002;745-751
12. Xiao W., Lin S.L., Broomfield S., Chow B.L., Wei Y.F. The products of the yeast MMS2 and two human homologs (hMMS2 and CROC-1) define a structurally and functionally conserved Ubc-like protein family. Nucleic Acids Research. 26(17):1998;3908-3914
13. Yu L.R., Zeng R., Shao X.X., Wang N., Xu Y.H., Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis. 21(14):2000;3058-3068